Literature DB >> 8549725

Survival differences in Austrian patients with the acquired immunodeficiency syndrome.

R Zangerle1, G Reibnegger, J P Klein.   

Abstract

We investigated the association of clinical and demographic factors on survival of the 901 AIDS cases diagnosed until 31 December 1992 and reported to the Austrian Health Authorities up to 20 January 1994. The overall estimated median survival of patients with AIDS increased substantially from 8 months in 1987 to 16 months in 1988, although this increase was not significant by the log-rank test. However, the differences in hazard rates were larger at the beginning of the survival curve: between 1987 and 1988 the proportion surviving at 1 year increased from 41 to 62%, compared to an increase of the proportion surviving at 2 years from 30 to 35% (Breslow test, p value 0.008). AIDS patients diagnosed between 1988 and 1992 (n = 755) were analyzed in more detail. Multivariate survival analysis revealed a shorter survival for those with residence in Eastern Austria, recipients of blood products, individuals with unknown transmission risk, those presenting with two AIDS indicator diseases and those with higher age at AIDS diagnosis. Candidal esophagitis as AIDS indicator disease was associated with longer survival. One hundred eighty-eight of the 755 AIDS patients (24.9%) died within the first 3 months after diagnosis of AIDS. We conclude that the survival time for AIDS patients has improved considerably after 1987, but survival is still very poor. Several factors have been shown to predict survival of patients with AIDS in Austria. Death within the first 3 months after the diagnosis of AIDS occurred at a relatively high frequency in Austrian AIDS patients. This may be caused by difficulties in the use of health care facilities or by the lack of awareness of HIV infection before diagnosis of AIDS either by patient or care provider.

Entities:  

Mesh:

Year:  1995        PMID: 8549725     DOI: 10.1007/bf01719303

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

1.  A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study Group.

Authors:  A N Phillips; F Antunes; G Stergious; A Ranki; G F Jensen; Z Bentwich; T Sacks; C Pedersen; J D Lundgren; A M Johnson
Journal:  AIDS       Date:  1994-06       Impact factor: 4.177

2.  Recent trends in Pneumocystis carinii pneumonia as AIDS-defining disease in nine European countries. Coordinators for AIDS Surveillance.

Authors:  M C Delmas; V Schwoebel; S H Heisterkamp; A M Downs; R A Ancelle-Park; J B Brunet
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-05-01

3.  The role of initial AIDS-defining illness in survival following AIDS.

Authors:  K Luo; M Law; J M Kaldor; A M McDonald; D A Cooper
Journal:  AIDS       Date:  1995-01       Impact factor: 4.177

4.  Survival of zidovudine-treated patients with AIDS compared with that of contemporary untreated patients. Italian Zidovudine Evaluation Group.

Authors:  S Vella; M Giuliano; P Pezzotti; M G Agresti; C Tomino; M Floridia; D Greco; M Moroni; G Visco; F Milazzo
Journal:  JAMA       Date:  1992-03-04       Impact factor: 56.272

5.  Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group.

Authors:  J D Lundgren; A N Phillips; C Pedersen; N Clumeck; J M Gatell; A M Johnson; B Ledergerber; S Vella; J O Nielsen
Journal:  JAMA       Date:  1994-04-13       Impact factor: 56.272

6.  Improved survival from diagnosis of AIDS in adult cases in the United Kingdom and bias due to reporting delays.

Authors:  S E Whitmore-Overton; H E Tillett; B G Evans; G M Allardice
Journal:  AIDS       Date:  1993-03       Impact factor: 4.177

7.  Trends in mortality among AIDS patients in Amsterdam, 1982-1988.

Authors:  P J Bindels; R M Poos; J T Jong; J W Mulder; H J Jager; R A Coutinho
Journal:  AIDS       Date:  1991-07       Impact factor: 4.177

8.  A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.

Authors:  M M Schneider; A I Hoepelman; J K Eeftinck Schattenkerk; T L Nielsen; Y van der Graaf; J P Frissen; I M van der Ende; A F Kolsters; J C Borleffs
Journal:  N Engl J Med       Date:  1992-12-24       Impact factor: 91.245

9.  Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993.

Authors:  D Osmond; E Charlebois; W Lang; S Shiboski; A Moss
Journal:  JAMA       Date:  1994-04-13       Impact factor: 56.272

10.  Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group.

Authors:  J D Lundgren; C Pedersen; N Clumeck; J M Gatell; A M Johnson; B Ledergerber; S Vella; A Phillips; J O Nielsen
Journal:  BMJ       Date:  1994-04-23
View more
  4 in total

1.  Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).

Authors:  R Thiébaut ; D Malvy; C Marimoutou; F Davis
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

2.  Trends in HIV seroprevalence, AIDS and prevention policy among intravenous drug users and men who have sex with men, before and after 1990 in Austria.

Authors:  F Piribauer; W Duer
Journal:  Eur J Epidemiol       Date:  1998-10       Impact factor: 8.082

3.  Health and federal budgetary effects of increasing access to antiretroviral medications for HIV by expanding Medicaid.

Authors:  J G Kahn; B Haile; J Kates; S Chang
Journal:  Am J Public Health       Date:  2001-09       Impact factor: 9.308

4.  Survival after AIDS diagnosis in Tuscany (Italy), 1985-1992.

Authors:  A Barchielli; S Acciai; V Lazzeri; E Buiatti
Journal:  Eur J Epidemiol       Date:  1997-02       Impact factor: 8.082

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.